Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA021866-001

ABILIFY(ARIPIPRAZOLE)

Other antipsychotics

Manufacturer: OTSUKA

FDA Approval: 20/09/2006

Route: INTRAMUSCULAR · INJECTABLE

Active Ingredients

ARIPIPRAZOLE 9.75MG/1.3ML (7.5MG/ML)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABILIFY — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.